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There is a continuing, worldwide rise in
breast cancer and other endocrine-related
cancers such as neoplasms of the testis and
prostate (1). In breast cancer, cumulative
exposure of breast tissue to the endogenous
hormone 17β -estradiol [1,3,5(10)-estra-
triene-3, 17β -diol] is thought to be one of
the main risk factors, and several epidemio-
logical studies have shown that risk is indeed
strongly linked to elevated serum levels of the
free, bioavailable hormone (2–4). However,
the rise in breast cancer is not explained
entirely by internal exposure to endogenous
hormones or genetic predisposition. It has
been suggested that environmental chemicals
that can mimic endogenous estrogens may
play a role in the development of the disease
(1), but this idea remains controversial.
Attempts to link cancer risks to environ-
mental chemicals are complicated by the fact
that their estrogenic potency is low com-
pared to that of 17β -estradiol. The disturb-
ing trends in the incidence of breast and
testicular cancer may therefore be difﬁcult to
explain simply in terms of exposure to
individual organochlorine compounds.
Several recent case–control studies of a
possible association between breast cancer
and serum levels of single chemicals such as
1-(o-chlorophenyl)-1-(p-chlorophenyl)-
2,2,2-trichloroethane (o,p´-DDT), 2,2-
bis(p-chlorophenyl)-1,1-dichloroethylene
(p,p´-DDE), or polychlorinated biphenyls
(PCBs) have yielded negative or inconclusive
results (5–7).
At any given time, human populations
are exposed to a multitude of agents with
estrogenic or estrogen-like activity—so-
called xenoestrogens or exoestrogens (8).
Through their lipophilicity and persistence,
many of these agents accumulate in adipose
tissue and are present in blood serum. They
are likely to act not only with each other but
also with endogenous estrogens. It is there-
fore crucial to assess the effects of mixtures
of xenoestrogens, a challenge regarded by
many government agencies and expert deci-
sion-making bodies all over the world as a
major research priority (9,10).
Unfortunately, the assessment of combi-
nation effects of xenoestrogens is hampered
by disputes and controversies. A report (11)
describing synergism between estrogenic pes-
ticides in a yeast reporter system could not
be reproduced (12,13) and was eventually
withdrawn (14). The ensuing debate has cast
doubt on the relevance of mixture effects of
xenoestrogens. Conclusive evidence of the
ability of estrogenic chemicals to produce
combination effects when present as mix-
tures is still missing. Recently, Shekhar et al.
(15) have contributed an analysis of the com-
bined effects of o,p´-DDT and 1,1-bis(p-
chlorophenyl)-2,2,2-trichloroethane
(p,p´-DDT) in MCF-7 human breast cancer
cells. They suggested that the presence of
p,p´-DDT led to enhanced responses in com-
bination with estradiol or o,p´-DDT.
However, Davidson and Yager (16) pointed
out that a lack of adequate dose–response
analyses in Shekhar and colleagues’ paper
complicated the interpretation of their data
and emphasized that accurate assessments of
combination effects in terms of synergism,
additivity, and antagonism require extensive
dose–response analyses.
These discussions have motivated us to
explore the combined effects of o,p´-DDT,
p,p´-DDE, β -hexachlorocyclohexane (β -
HCH), and p,p´-DDT, ubiquitous environ-
mental pollutants that can be found in the
adipose tissue of human subjects. All four
compounds can induce cell proliferation in
estrogen-dependent breast cancer cells
(17,18), but exert their effects in differing
and often poorly understood ways. Two of
the chemicals, o,p´-DDT and p,p´-DDT, are
estrogen receptor agonists (17,19), whereas
β -HCH and p,p´-DDE stimulate cell divi-
sion independent of estrogen receptor-medi-
ated pathways (18,20). The ﬁrst aim of our
studies was to assess whether the four chosen
agents can act together in causing cell prolif-
eration in MCF-7 cells.
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In view of the large differences between the concentrations of estrogenic chemicals needed to
elicit effects in in vitro assays and their levels in human tissues, it is hard to explain possible
health risks in terms of exposure to individual compounds. Human populations, however, are
exposed to mixtures of estrogenic and estrogen-like agents and it is necessary to consider the
impact of combined effects. We assessed the combined effects of 1-(o-chlorophenyl)-1-(p-
chlorophenyl)-2,2,2-trichloroethane (o,p´-DDT), 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene
(p,p´-DDE), β -hexachlorocyclohexane (β -HCH), and 1,1-bis(p-chlorophenyl)-2,2,2-
trichloroethane (p,p´-DDT) on the induction of cell proliferation in MCF-7 cells. All four com-
pounds are persistent organochlorines that can be found in human tissues. We performed
extensive concentration–response analyses with the single agents to predict the effects of two mix-
tures of all four compounds with different mixture ratios. We calculated the predictions by using
the pharmacologically well-founded models of concentration addition and independent action
and then tested them experimentally. o,p´-DDT, p,p´-DDE, β -HCH, and p,p´-DDT acted
together to produce proliferative effects in MCF-7 cells. The combined effect of the four agents
could be predicted on the basis of data about single agent concentration–response relationships.
Regression analysis demonstrated that there were combination effects even when each mixture
component was present at levels at or below its individual no-observed-effect-concentration. We
assessed combination effects in two ways: First, evaluations in relation to the proliferative
responses induced by single mixture components revealed that the combination effects were
stronger than the effects of the most potent constituent. Thus, according to this method of evalu-
ation, the combined effects may be termed synergistic. Second, comparisons with the expected
effects, as predicted by concentration addition and independent action, showed excellent agree-
ment between prediction and observation. With this approach, the combined effect of all four
compounds can be termed additive. Key words: breast cancer, E-Screen assay, estrogenic agents,
MCF-7 cells, mixture effects, organochlorine compounds. Environ Health Perspect 109:391–397
(2001). [Online 27 March 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p391-397payne/abstract.htmlThe combined effects of mixtures of
agents are commonly assessed in terms of
synergism, additivity, or antagonism. Such
evaluations critically rely on quantitative
estimations of what the expected effect of a
mixture should be. If the observed responses
are stronger or weaker than expected, the
combined effect can be called synergistic or
antagonistic, respectively. If expectations are
met, the mixture effect is considered additive
(21).
Combination effects are also frequently
evaluated in relation to the effects of the
most potent individual mixture components.
Thus, synergism is thought to exist when the
mixture effect exceeds those of the most
effective single component (22,23). For our
analysis we have used both approaches to
evaluating combination effects.
Two main ways of modeling quantita-
tively the expected effects of mixtures can be
distinguished. Some methods use informa-
tion about underlying mechanisms of action
to describe expected mixture effects (24,25).
Alternatively, quantitative estimations of
expected mixture effects can be derived from
data about concentration–response relations
of the individual mixture constituents
("mechanism-free" approach) (26).
The mechanistic approach has merits
with simple systems such as isolated proteins
or enzymes, but leads to problems where the
mode of action of agents and other interac-
tions between agent and organism are insuf-
ficiently understood. The fragmentary
knowledge of the ways in which o,p´-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT induce
cell proliferation restricted our choice to
mechanism-free concepts for defining
expected combination effects. Here, only
"inputs" (i.e., concentrations of test agents)
and "outputs" (i.e., cell proliferation) are
regarded as accessible to analysis, while the
test system itself (i.e., the processes of uptake
of test agents into cells, metabolism, induc-
tion of signaling pathways leading to cell
division, and the like) is considered a "black
box.” As long as the effects of individual
agents and mixtures are analyzed within the
same system and in relation to identical end-
points, mixture effects can be predicted from
the potency of individual agents, regardless
of the complexities of the system (26).
A second aim of our studies was to evalu-
ate whether mixture effects of o,p´-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT can be
accurately predicted on the basis of informa-
tion about concentration–response relation-
ships of individual agents. A popular and
widely used method of calculating expected
mixture effects from data about the potency
of individual mixture constitutents assumes
that the combined additive effect of a mix-
ture should always be equal to the arithmetic
sum of the effects of its components (13,15,
27–30). Deviations from this expectation are
then classiﬁed as synergisms or antagonisms.
It is frequently overlooked that this concept,
termed effect summation, can be applied
only to linear dose–response curves. It leads
to unreliable predictions when applied to the
sigmoidal curves usually seen with estrogenic
agents (26,31,32). For this reason, we did
not adopt effect summation for the present
studies.
Instead, we employed concepts that can
be applied to sets of compounds with non-
linear dose–response curves. The two refer-
ence models of concentration addition and
independent action are well suited for such
purposes. Concentration addition goes back
to Loewe and Muischnek (33) and rests on
the assumption that chemicals act in a simi-
lar way. The model states that effects can be
produced by replacing one compound
totally or partly with other constituents.
Each component is thought to contribute to
the overall mixture effect by acting in pro-
portion to its concentration, even below
threshold concentrations. Independent
action was originally developed by Bliss (34)
on the basis of stochastic considerations and
assumes that compounds act on different
subsystems in organisms, with different sites
of action. When present at subthreshold
doses, mixture components will not con-
tribute to the overall mixture effect.
In the past there have been acrimonious
disputes about the general applicability of
either model, but now both are regarded as
equally valid methods for predicting combi-
nation effects (35). Consequently, we have
used both models side by side to calculate
expected effects of two mixtures with differ-
ing mixture ratios. We then tested the expec-
tations experimentally. This so-called fixed
mixture ratio design lends itself to analyzing
the effects of multiple mixtures, particularly
at low effect concentrations. It was given
preference over the "classical" pharmacologi-
cal design, where the concentration of one
agent is held constant and the influence of
varying concentrations of a second agent are
studied (36). With this experimental
approach, the study of combination effects
at low concentrations of all mixture compo-
nents is not possible because one mixture
constituent is always present at a concentra-
tion that produces signiﬁcant effects. 
We measured the stimulation of cell pro-
liferation in MCF-7 human mammary
epithelial cells. This assay is regarded as a rel-
evant model system for assessing the effects
of estrogenic and estrogen-like agents (16).
Materials and Methods
MCF-7 Cell Proliferation Assay. MCF-7
cells were maintained in 75 cm2 cell culture
ﬂasks (Greiner, Frickenhausen, Germany) in
Dulbecco’s modified Eagle’s medium
(DMEM; Gibco BRL, Paisley, UK) supple-
mented with 5% heat inactivated fetal calf
serum (FCS; Gibco BRL). These were kept
in a humidified incubator, 37°C, 5% CO2
over a maximum of 15 passages and were
routinely tested for mycoplasma. 
Estradiol was removed from pooled
human serum (National Blood Transfusion
Service, London, UK) by treatment with
charcoal and dextran, as previously described
(17), and stored at –20°C for up to 6
months. 
The assay was carried out using a modiﬁ-
cation of Soto’s E-SCREEN protocol
(17,37). Brieﬂy, one 70% conﬂuent 25 cm2
ﬂask of MCF-7 cells was washed with 5 mL
phosphate buffered saline (PBS; Sigma,
Poole, Dorset, UK) and trypsinized. Cells
were resuspended in 20 mL DMEM + 5%
FCS, counted and seeded to 12-well plates
(Corning, Cambridge, MA, USA) at a den-
sity of 1 × 104 cells per well in 1 mL
DMEM with 5% FCS (full medium). After
24 hr the cells were washed with 1 mL PBS.
The medium was changed to 1 mL estrogen-
free medium [phenol red-free DMEM with
5% charcoal-dextran stripped human serum
(CDHus)] and left for a further 72 hr.
Again, the medium was changed to 1 mL
estrogen-free medium, with test compounds
added at a range of concentrations. We
assessed cell proliferation after 7 days in cul-
ture using the method of Skehan et al. (38).
Brieﬂy, cells were ﬁxed in cold 10% [weight
per volume (w/v)] trichloroacetic acid for 30
min, washed 5 times with water and stained
with 0.4% (w/v) sulforhodamine B (SRB;
Sigma) in 1% acetic acid for 10 min.
Unbound SRB was removed by washing in
1% acetic acid, and bound SRB was solubi-
lized with 10 mM Tris pH 10.4. Dye inten-
sity was measured at 510 nm on a plate
reader (Labsystems Multiskan, UK). It was
shown to increase linearly with cell number
(data not shown).
o,p´-DDT (Lancaster, Morecambe,
UK; purity > 99%), p,p´-DDT and p,p´-
DDE (Sigma; purity 98%), and β -HCH
(J.T.Baker, Milton Keynes, UK; purity
98%) were made up as 1 mM stock solu-
tions in absolute ethanol, diluted in
ethanol, and administered to cell cultures so
that the ﬁnal ethanol concentration did not
exceed 1% in the media. Solutions of con-
centrations greater than 1 mM were not
made because of concerns about solubility.
Nominal concentrations were used. We
measured cell proliferation relative to control
cultures kept with 1% ethanol in the
medium. Ethanol alone, at 1%, had no
influence on cell proliferation. We chose
phenol red-free DMEM because phenol red
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human serum over fetal calf serum because
of widespread use of growth hormones in
cattle, which may interfere with responses. 
Data processing. In the MCF-7 assay,
absorbance readings of SRB-stained cultures
(a direct measure of cell numbers) were com-
pared with readings from untreated controls
and expressed as -fold increases. To obtain
concentration–response curves with zero
effect, we defined control values as 1 and
subtracted them from the readings obtained
with treated cultures. Thus, a proliferative
effect of "0.3" represents a 0.3 + 1 = 1.3-fold
increase in cell numbers relative to controls.
Concentration–response analysis and sta-
tistical analysis. We constructed scatter plots
of relative cell proliferation (MCF-7 assay)
versus log concentration and performed con-
centration–response analyses using the "best
fit" approach (40). We chose appropriate
regression models from a large set of differ-
ent models, including the commonly used
Probit, Logit, Weibull, and Hill models.
For each data set we compared the quality
of fit and selected the model yielding the
best fit for final data analysis. To account
for possible heterogeneities in effect vari-
ances (heteroscedasticity), we estimated the
fit parameters by using the iteratively
reweighted least-squares procedure in com-
bination with a nonparametric variance
model (41). Except for the data for the
equimolar mixture of all four agents, the
three parameter Langmuir function pro-
duced the best ﬁts for all data sets. The data
for the equimolar mixture were best ﬁtted by
using the four parameter Box-Cox-Logit
function (i.e., the logit function with an
integrated Box-Cox transformation of the
concentration scale; see Table 1).
The 95% confidence belts of estimated
mean effects were also determined. All statis-
tical analyses were performed using SAS soft-
ware (42). Table 1 shows a compilation of
the non-linear regression models used in this
study.
No-observed-effect-concentrations
(NOEC) of single agents and mixtures were
estimated by using the Dunnett test (43).
Mixture testing. We prepared two master
solutions of mixtures by diluting 1 mM
stocks of each agent, with molar mixture
ratios of 1:1:1:1 and 1:10:5:4 (o,p´-
DDT:p,p´-DDE:β -HCH:p,p´-DDT). The
mixture ratio of the first mixture approxi-
mates the ratio of effect concentrations of
the individual agents that produce a dou-
bling in cell number. The ratio of the second
mixture was chosen to fall in the range of the
relative abundance of each of the four
organochlorines in human serum in Western
industrialized countries (Table 2). We
treated MCF-7 cells with serial dilutions of
these master solutions. We ran samples in
triplicate and repeated experiments at least
twice, so that each concentration–response
curve was based on a minimum of 30 obser-
vations. We computed predicted mixture
effects over a large range of effects and tested
the predictions experimentally.
Calculation of predicted mixture effects.
The model of concentration addition pre-
dicts a concentration of a mixture of agents
that produces a predetermined effect.
Prerequisites for the calculation of such
effect concentrations are information about
the relative abundance of an agent in the
mixture (mixture ratio) and data on the con-
centrations of each mixture component that
individually produces this same effect. Thus,
assuming that the combined effect of the
mixture with n components is concentration
additive, the following expression will hold
for any effect level E:
Σ ci/ECi = 1, [1]
where ci denotes the concentration of agent i
in a mixture yielding an effect E, and ECi
the concentration of i needed to produce
effect E on its own. Equation 1 can be used
to calculate a mixture concentration that
produces a predetermined effect, provided
the ECi of the individual mixture compo-
nents and their relative abundance in the
mixture are known. Thus, the concentration
ci of agent i in the mixture is related to the
total mixture concentration by
ci = pi * ECmix, [2]
where pi is the concentration of the ith com-
pound relative to the total mixture concentra-
tion ECmix that is required to produce effect
E. Substitution of ci in Equation 1 gives
Σ (pi * ECmix/ECi) = 1, [3]
and rearranging yields
ECmix = [Σ pi/ECi]-1. [4]
The effect concentrations ECi were cal-
culated from the best fits of the concentra-
tion–response models of single agents by
using the inverse expression of the appropri-
ate regression functions (Table 1).
The model of independent action allows
it to calculate the predicted effects emix of a
mixture of known composition by using the
expression
emix = 1 – ∏ [1 – E(ci)], [5]
where E(ci) is the effect E produced by com-
pound i at concentration c, when applied
singly. It can be seen from Equation 5 that
independent action is a probabilistic model,
i.e., E(ci) is a fraction of a maximal possible
effect that cannot exceed 1.
Thus, when this model is applied to pro-
liferative effects PE(ci), a maximal effect
Emax must be deﬁned. For this purpose, the
maximal proliferative effect of saturating
concentrations of 17β -estradiol was chosen
as a reference point and the effects of test
agents expressed relative to the maximal
effect of 17β -estradiol:
E(ci) = PE(ci)/Emax. [6] 
If the concentration–response relation-
ships of all mixture constituents i are
described by an appropriate regression model
Fi (Table 1), the proliferative effect PE(ci) can
be estimated from the mean effect Fi(ci) pre-
dicted by the regression model. Thus,
PE(ci) = Fi(ci), and E(ci) = Fi(ci)/Emax. [7]
Substitution of E(ci) in Equation 5 yields
emix = 1 – ∏ [1 – Fi(ci)/Emax]. [8].
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Table 1. Nonlinear regression functions employed in this study.
Name Formula
Langmuir P(conc) = 1/(θ 1 + θ 2 (conc)(–θ
3
–1))
Logit with Box-Cox transformation  P(conc) = 1/{1 + exp[–θ 1 –θ 2(conc θ
3 – 1)/θ 3]}
P(conc) is the mean effect; θ 1, θ 2, and θ 3 are model parameters; and conc is the concentration of the test agent.
Table 2. Levels of o,p´-DDT, p,p´-DDE, β -HCH, and p,p´-DDT in human blood serum.
Range of levels in Levels selected to
Compound blood serum (nM)a construct mixture (nM)b References
o,p´-DDT 0.3–2 1 (44,45)
p,p´-DDE 8–135 10 (44–47)
β -HCH 1–53 5 (44,45,48)
p,p´-DDT 0.4–21 4 (5,44,45,48)
aData were compiled from the references given. Where necessary, adipose tissue levels were converted to serum lev-
els, assuming that serum levels are typically 250 times lower than adipose tissue levels (49). bThis is equivalent to a
1:10:5:4 molar mixture ratio.To ensure comparability of the indepen-
dent action predictions with those of con-
centration addition, the fractional effects in
Equation 8 were rescaled by multiplication
with Emax, thus:
Emix = Emax * emix and [9]
Emix = Emax (1 – ∏ [1 – Fi(ci)/Emax]). [10].
Results
Concentration–response analyses for o,p´-
DDT, p,p´-DDE, β -HCH, and p,p´-DDT.
In agreement with previously reported data
(17,50) all four agents were able to induce
cell proliferation in MCF-7 cells in a typical
concentration-dependent manner (Figure 1).
The concentration–response plots showed
marked differences in shape and position.
o,p´-DDT was the most potent of our agents,
with a concentration of 0.89 µM yielding an
effect of 2 on the effect scale. However, it
elicited the smallest maximal effect (2.7) of
all four selected chemicals. The largest tested
concentration of p,p´-DDE showed an effect
of 3.9, but the compound was less potent than
o,p´-DDT, with a displacement of the concen-
tration–response curve toward higher concen-
trations. p,p´-DDT and β -HCH produced
concentration–response curves that were
almost congruent. Their potency was compa-
rable to that of p,p´-DDE. "Thresholds" were
defined as those effect concentrations that
correspond to an intersection of the lower
95% confidence interval of mean effects of
the regression model with the upper 95%
confidence interval of the estimate for
untreated control cultures (0 ± 0.035, n =
15). NOECs are also depicted. Because of
concerns over limited aqueous solubility of
the compounds, we did not test nominal
concentrations higher than 10 µM. For this
reason, the observed concentration-effect
data for p,p´-DDT and β -HCH do not
show the leveling off of effects theoretically
expected at higher concentrations.
17β -Estradiol was employed as a positive
control and produced a maximal response of
5.9, with a median effect concentration
EC50 of 13.3 pM (37), in excellent agree-
ment with earlier reports (50). Table 3 sum-
marizes key parameters of the relative
potency of all four tested agents.
Our results agree broadly with those com-
municated by Andersen and colleagues (50)
and Soto et al. (17), but a lack of published
data on quantitative concentration–response
relationships with organochlorines precluded
us from making more detailed direct compar-
isons between our observations and previous
reports. However, in contrast to the data
reported by Shekhar and coworkers (15), we
found p,p´-DDT to be a weaker mitogen
than o,p´-DDT, mainly because o,p´-DDT
produced higher responses in our hands than
those reported by Shekhar et al.; the mito-
genic effects observed with p,p´-DDT agree
excellently with their data.
To probe the involvement of estrogen
receptor activation in MCF-7 cell prolifera-
tion, we assessed the effects of the estrogen
receptor antagonist tamoxifen. Co-incuba-
tions with tamoxifen (1 nM) led to marked
reductions in cell proliferation induced by
o,p´-DDT and p,p´-DDT, but left the
effects of p,p´-DDE and β -HCH unchanged
(data not shown). In line with these observa-
tions, o,p´-DDT and p,p´-DDT were able to
activate estrogen receptors in a yeast-based
reporter plasmid system [yeast estrogen
screen, performed exactly as described by
Routledge and Sumpter (51)], whereas p,p´-
DDE and β -HCH led only to insigniﬁcant
effects (data not shown). 
The effects of mixtures of o,p´-DDT, p,p´-
DDE, β -HCH, and p,p´-DDT: prediction
and observation. We used the single agent
concentration–response relationships shown in
Figure 1 to predict concentration–effect curves
for mixtures of all four agents, assuming addi-
tive combination effects. The predictions were
computed using the models of concentration
addition and independent action. Mixtures
with two different mixture ratios were investi-
gated, one equimolar (Figure 2A) and the
other employing molar mixture ratios that fall
in the range of the relative prevalence of the
four chemicals in human blood serum, o,p´-
DDT: p,p´-DDE : β -HCH : p,p´-DDT =
1:10:5:4 (Figure 2B).
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Figure 1. Concentration–response analyses for o,p´-DDT (A), p,p´-DDE (B), β -HCH (C), and p,p´-DDT (D) in
the MCF-7 cell proliferation assay. Data were ﬁtted to the Langmuir function using iteratively reweighted
least squares. For p,p´-DDT, least squares were used. Solid curved lines represent the best fits to the
Langmuir function; dotted lines are the upper and lower 95% confidence intervals (CIs) of mean
responses. The horizontal solid and dashed lines are mean ± 95% CI of the population mean of untreated
controls. Arrows represent NOECs estimated using the Dunnett test, or threshold levels as deﬁned in the
legend to Table 3. Experiments were performed in triplicate and repeated independently.
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Table 3. Summary of characteristics of single agent- and mixture-concentration response relationships.
o,p´-DDT p,p´-DDE β -HCH p,p´-DDT 1:1:1:1 mix 1:10:5:4 mix
Number of effect data 41 49 25 31 83 36
Nonlinear regression model Langmuir Langmuir Langmuir Langmuir Box-Cox-Logit Langmuir
Concentration producing  0.89 µM 3.16 µM 2.45 µM 5.62 µM 1.74 µM 3.31 µM
effect of 2a,b
Maximal effecta 2.7 ND ND ND 3.1 2.5
NOECc 0.2 µM 0.4 µM 0.2 µM 0.1 µM 0.2 µM 0.7 µM
Threshold leveld 0.35 µM 0.34 µM 0.075 µM 0.037 µM 0.018 µM 0.50 µM
Abbreviations: Mix, mixture. ND, no data. 
aRelative cell proliferation as deﬁned in “Materials and Methods.” bEffect concentrations were estimated by using the best ﬁt
regression models. cThe largest tested concentration that produced effects not signiﬁcantly different from those of untreated
controls. Determined using the Dunnett test. dThe intersection of the upper 95% conﬁdence interval of the mean response of
untreated controls (0 ± 0.0353, n = 15) with the lower 95% conﬁdence interval of the best ﬁt of the regression model.In the concentration range below 4 µM,
the two models yielded very similar predic-
tions, although the responses in the linear
portion of the curves expected on the basis
of independent action were slightly smaller
than those predicted by concentration addi-
tion. There were, however, differences in the
predicted maximal effects of the equimolar
mixture. Although the concentration addi-
tion predictions began to plateau off at con-
centrations exceeding 4 µM, independent
action projected a continuous increase with
concentration (Figure 2A). Because the con-
centration addition concept calculates con-
centrations corresponding to predetermined
effects, mixture responses higher than the
lowest maximal effect induced by one of the
mixture components alone (here, o,p´-DDT;
see Figure 1) cannot be predicted. Therefore,
the line representing the concentration addi-
tion prediction in Figure 2B cannot be
extended to higher concentrations.
The responses of both mixtures were
tested experimentally on the basis of the
range of the predicted effect concentrations.
As shown in Figure 2, a concentration-
dependent increase in cell proliferation was
observed. The effects were reproducible,
with variabilities comparable to those seen
with the single agents.
Assessment of combination effects. We
assessed the combined effects of o,p´-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT on
MCF-7 cell proliferation in relation to the
effects of the most potent mixture compo-
nent and in relation to the expected
responses, as predicted by the models of con-
centration addition and independent action.
Assessments of combination effects with
respect to the responses of an individual
mixture component require the data to be
presented not in relation to the total concen-
tration of all mixture components, as in
Figure 2, but with re-scaled axes that show
the concentration of individual agents in the
mixtures. Such plots are presented in Figure
3. In the case of the equimolar mixture, the
analysis was performed in relation to o,p´-
DDT, the most potent of all four com-
pounds. Given its abundance in the 1:10:5:4
mixture, p,p´-DDE was deemed the most
potent mixture component, and mixture
responses were plotted using an axis depict-
ing p,p-DDE concentrations in the mixture.
With the equimolar mixture, the pres-
ence of p,p´-DDE, β -HCH, and p,p´-DDT
led to increases of the effects of o,p´-DDT
(Figure 3A). Although particularly marked
in the median effect range, increases were
also discernible at low effect concentrations.
Except in the very low effect range, there was
no overlap of the 95% confidence intervals
of the mixture- and the single-agent regres-
sion models. We therefore became interested
in assessing whether the threshold level of
o,p´-DDT was altered by the presence of the
other mixture components. Thus, for o,p´-
DDT administered individually, a threshold
concentration of 0.35 FM can be estimated.
This value changed to 4.4 nM in the
equimolar mixtures (Figure 3A).
Similar trends became apparent with the
1:10:5:4 mixture. The presence of the
remaining mixture components exacerbated
the effects of p,p´-DDE. There was a small
change of the threshold of p,p´-DDE from
0.34 FM when applied individually to 0.25
FM in the mixture.
Assessments in relation to the model pre-
dictions showed that the combination effects
of o,p´-DDT, p,p´-DDE, β -HCH, and p,p´-
DDT did not deviate signiﬁcantly from the
additivity expectations of the models of
concentration addition and independent
action (Figure 2). Applying the criterion of
overlap between the prediction curves and
the 95% confidence belts of the best fit
regression models of observed effects, no
marked deviations could be identified.
However, both models slightly overestimated
the effects of the 1:10:5:4 mixture in the low
effect range. At maximum effect concentra-
tions the observed mixture responses began
to plateau off, a feature modeled well by con-
centration addition for the equimolar mix-
ture (Figure 2A). With both mixtures the
performance of independent action was poor
in this effect range.
Mixture effects at low effect concentra-
tions of individual mixture constituents. We
also considered whether o,p´-DDT, p,p´-
DDE, β -HCH, and p,p´-DDT in combina-
tion were able to produce effects at low
effect concentrations. To this end, we ana-
lyzed combination effects for mixture con-
centrations where each agent was present at
or below its individual NOEC. At a concen-
tration of 0.4 FM of the equimolar mixture,
each agent was present at 0.1 FM. This con-
centration equals the NOEC for p,p´-DDT
Articles • Mixture effects of organochlorines
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Figure 2. Predicted and observed mixture effects of a 1:1:1:1 (molar ratio) mixture (A) and a 1:10:5:4 (molar
ratio) mixture (B) of o,p´-DDT, p,p´-DDE, β -HCH, and p,p’-DDT. Observed mixture effects are shown as
blue circles and are triplicates from two to three independent experiments. Predicted effects were calcu-
lated using the models of concentration addition (CA) and independent action (IA) and are shown as solid
and dotted lines, respectively. The dashed curves are the best fit of the data to the regression model
(1:1:1:1 mixture: Box-Cox-Logit function; 1:10:5:4 mixture: Langmuir function) and dotted lines are the
upper and lower 95% CIs of mean responses. Arrows represent NOECs estimated using the Dunnett test,
or threshold levels as deﬁned in Table 3.
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Figure 3. Comparison of mixture effects with the responses of the most potent mixture component.
Mixture effects shown in Figure 2 were replotted with concentration axes showing the concentrations of
o,p´-DDT in the 1:1:1:1 mixture (A) and of p,p´-DDE in the 1:10:5:4 mixture (B). Observed mixture effects are
shown as blue circles, with dashed solid lines and dotted lines depicting the best ﬁt and the upper and
lower 95% CIs, respectively. Solid sigmoidal lines are the best ﬁt regression models for o,p’-DDT (A) and
p,p´-DDE (B). Vertical arrows are threshold levels as deﬁned in Table 3.
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in mixtureand is well below the NOECs estimated for
the remaining three agents (Table 3). For a
concentration of 0.4 FM of the equimolar
mixture, the regression model predicts an
effect of 0.31, with a 95% conﬁdence inter-
val of ± 0.07 (Figure 2A). This effect is well
above the responses seen with untreated con-
trol cultures (0 ± 0.035). Because the mix-
ture ratio of the 1:10:5:4 mixture was too
dissimilar from the ratio of the NOECs of
the mixture components, a similar analysis
could not be performed in this case.
Discussion
The assessment of combination effects of
estrogenic and estrogen-like agents has in the
past been fraught with experimental and con-
ceptual problems [reviewed in Kortenkamp
and Altenburger (31,32)]. The events leading
to the withdrawal of Arnold and colleagues’
paper (11,14) have polarized views even fur-
ther. Although it is widely acknowledged that
the potential for interactions between xenoe-
strogens exists (8,10), conclusive experimen-
tal evidence was lacking. To ﬁll this gap we
present here an assessment of the combined
effects of the persistent organochlorines o,p´-
DDT, p,p´-DDE, β -HCH, and p,p´-DDT
in the induction of cell proliferation in
MCF-7 cells. We have underpinned our eval-
uation with extensive concentration–response
analyses. Our results show clearly that the
four tested agents act together to produce
combination effects.
In assessing combinations of o,p´-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT we com-
pared the observed mixture responses with the
effects of the most potent individual mixture
constituent on the one hand, and with model
expectations on the other. Both approaches are
well recognized in pharmacology (21–23,26).
Our results show clearly that the
observed mixture responses were larger than
the proliferative effects of the most potent
mixture component. In the equimolar mix-
ture, concentrations of o,p´-DDT that on
their own would have failed to produce mea-
surable effects led to signiﬁcant cell prolifera-
tion in the presence of the remaining three
mixture components. This was accompanied
by a large shift of the individual threshold of
o,p´-DDT toward lower concentrations. The
magnitude of this change is related to the cur-
vature of the mixture concentration–response
curve, which is shallower in the low effect
range than the o,p´-DDT curve. Similarly, the
proliferative responses of the 1:10:5:4 mixture
were stronger than the individual effects of
p,p´-DDE, although due to the mixture ratio
the differences were not as pronounced as
with the equimolar mixture in relation to
o,p´-DDT. The small shift of the individual
threshold of p,p´-DDE toward lower con-
centrations was deemed insigniﬁcant.
When evaluated in relation to the addi-
tivity expectations of the models of concen-
tration addition and independent action, the
observed mixture effects of o,p´-DDT, p,p´-
DDE, β -HCH, and p,p´-DDT agreed well
with the predicted effects. Although the
model of concentration addition was better
suited to predict the leveling off of effects
seen at higher mixture concentrations, both
models performed equally well in the low
and median effect range. Thus, for the ﬁrst
time we demonstrate that the proliferative
effects of mixtures of estrogenic and estro-
gen-like agents can be predicted on the basis
of concentration-effect data of individual
mixture components. These predictions
appeared to be valid over a large range of
effect levels for two different mixture ratios.
Our results are relevant to evaluations of
mixture effects of estrogenic or estrogen-like
agents at low effect concentrations. At 0.4
FM of the equimolar mixture each single
mixture component was present at 0.1 FM,
a concentration equal to (p,p´-DDT) or
below (o,p´-DDT, p,p´-DDE, β -HCH)
their individual NOECs (see Table 3). At
this point, the best ﬁt regression model pre-
dicts effects well above those of untreated
controls (Figure 2). Although mixture effects
were not tested experimentally at 0.4 FM,
these data strongly suggest that o,p´-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT can
induce cell proliferation when present at or
below their individual NOECs. This is fur-
ther underlined by considering the lowest
tested concentration (0.7 FM) that induced
significant responses. Here, the concentra-
tion of each agent was 0.175 FM—i.e.,
below the NOECs of o,p´-DDT, p,p´-DDE,
and β -HCH, but higher than the NOEC of
p,p´-DDT, although the effects of p,p´-
DDT were small in this range. Because the
composition of the 1:10:5:4 mixture was not
in proportion to the NOECs of its compo-
nents, it is hard to demonstrate that combi-
nation effects occurred at low effect
concentrations in this case. To establish con-
clusively whether there are combination
effects when all individual mixture con-
stituents are present at concentrations that
induce unmeasurable, statistically insignifi-
cant effects, it will be necessary to conduct
studies of mixtures with far more than four
components. 
It is informative to consider the differ-
ences among the concentrations of single
agents that are needed to elicit effects in the
in vitro cell proliferation assay and their levels
in human tissues. A graphic representation
of key data is given in Figure 4. It shows that
the concentrations of o,p´-DDT, p,p´-DDE,
β -HCH, and p,p´-DDT that individually
produce observable effects in the MCF-7 cell
proliferation assay are 100- to 1,000-fold
higher than their levels in human blood
serum. Thus, it appears unlikely that the
four tested compounds can individually
induce MCF-7 cell proliferation at the con-
centrations found in serum. Crucially, how-
ever, the gap between physiological levels
and concentrations effective in vitro reduces
to about 10-fold when comparisons are
made with the concentration (1 FM) that
produced measurable effects in the 1:10:5:4
mixture of all four agents (Figure 4). Further
work with mixtures composed of a larger
number of xenoestrogens is required to
probe whether there are effects at physiologi-
cal levels. However, this issue is complicated
by uncertainties as to what constitutes rele-
vant "physiological levels" of persistent
organochlorines in a breast cancer context.
Shekhar and colleagues (15) have pointed
out that the levels of xenoestrogens detected
in adipose tissue of human breast cancers
can be about 1,000-fold higher than their
levels in serum. Given the close proximity
between the epithelial cells that line the milk
ducts of the female breast and the surround-
ing adipocytes, it may be possible that
epithelial cells are exposed to higher levels of
xenoestrogens than suggested by blood
serum levels.
Taken together, our results highlight
the importance of taking mixture effects
into account when assessing the effects of
estrogenic and estrogen-like agents. If it is
problematic to explain human health risks in
terms of exposure to individual agents, the
challenge lies in assessing the effects of multi-
ple mixtures of xenoestrogens. It is hard to
see how the health risks potentially associated
Articles • Payne et al.
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Figure 4. Comparison of the levels of o,p’-DDT,
p,p´-DDE, β -HCH, and p,p´-DDT in blood serum
(horizontal lines) with the range of observed
effects of the single compounds in the MCF-7 cell
proliferation assay (curved lines). The same sym-
bols were used for each agent: o,p´-DDT (dot-
dashed lines), p,p´-DDE (dashed lines), β -HCH
(dotted lines), and p,p´-DDT (thin solid lines). The
vertical arrows pointing to the respective single
agent curves depict the concentrations at which
each agent was present in 1 µM of the 1:10:5:4
mixture. This was the lowest tested concentration
that produced effects significantly different from
untreated controls (Figure 2B). 
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taking mixture effects into consideration.
In conclusion, our study shows that o,p´-
DDT, p,p´-DDE, β -HCH, and p,p´-DDT
act together to produce proliferative effects
in MCF-7 cells, and that the combined
effect of the four agents can be predicted on
the basis of data about single-agent concen-
tration–response relationships. With respect
to quantitative expectations based on the
potencies of individual mixture components,
the combined effect of the four organochlo-
rines can be called additive. In relation to the
most potent component of either of the two
mixtures, the combination effect can be
classed as synergistic. Our ﬁndings strongly
suggest that there are mixture effects even
when each mixture component is present at
concentrations that individually produce
insigniﬁcant effects.
One crucial step to establishing whether
xenoestrogens contribute to breast cancer
risks is to probe whether they can exert an
impact on the already strong effects of
endogenous steroidal estrogens when com-
bined at physiological concentrations. Our
work provides a rationale for the design of
experimental studies addressing this problem.
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